Literature DB >> 2657399

Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene.

T P Mäkelä1, K Saksela, K Alitalo.   

Abstract

The N-myc and c-myc genes encode closely related nuclear phosphoproteins. We found that the N-myc protein from human tumor cell lines appears as four closely migrating polypeptide bands (p58 to p64) in sodium dodecyl sulfate-polyacrylamide gels. This and the recent finding that the c-myc protein is synthesized from two translational initiation sites located in the first and second exons of the gene (S. R. Hann, M. W. King, D. L. Bentley, C. W. Anderson, and R. N. Eisenman, Cell 52:185-195, 1988) prompted us to study the molecular basis of the N-myc protein heterogeneity. Dephosphorylation by alkaline phosphatase reduced the four polypeptide bands to a doublet with an electrophoretic mobility corresponding to the two faster-migrating N-myc polypeptides (p58 and p60). When expressed transiently in COS cells, an N-myc deletion construct lacking the first exon produced polypeptides similar to the wild-type N-myc protein, indicating that the first exon of the N-myc gene is noncoding. Furthermore, mutants deleted of up to two thirds of C-terminal coding domains still retained the capacity to produce a doublet of polypeptides, suggesting distinct amino termini for the two N-myc polypeptides. The amino-terminal primary structure of the N-myc protein was studied by site-specific point mutagenesis of the 5' end of the long open reading frame and by N-terminal radiosequencing of the two polypeptides. Our results show that the N-myc polypeptides are initiated from two alternative in-phase AUG codons located 24 base pairs apart at the 5' end of the second exon. Both of these polypeptides are phosphorylated and localized to the nucleus even when expressed separately. Interestingly, DNA rearrangements activating the c-myc gene are often found in the 1.7-kilobase-pair region between the two c-myc translational initiation sites and correlate with the loss of the longer c-myc polypeptide. Thus the close spacing of the two N-myc initiation codons could explain the relative resistance of the N-myc gene to similar modes of oncogenic activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657399      PMCID: PMC362571          DOI: 10.1128/mcb.9.4.1545-1552.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  MC29 virus-coded protein occurs as monomers and dimers in transformed cells.

Authors:  J P Bader; D A Ray
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

Review 2.  Evolution of tumours and the impact of molecular oncology.

Authors:  G Klein; E Klein
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

3.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

4.  N-myc can cooperate with ras to transform normal cells in culture.

Authors:  G D Yancopoulos; P D Nisen; A Tesfaye; N E Kohl; M P Goldfarb; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

5.  Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

Authors:  J H McCutchan; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

6.  Differential expression of intermediate filament proteins distinguishes classic from variant small-cell lung cancer cell lines.

Authors:  J L Broers; D N Carney; L de Ley; G P Vooijs; F C Ramaekers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

8.  Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture.

Authors:  M Schwab; H E Varmus; J M Bishop
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

9.  Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.

Authors:  C J Thiele; C P Reynolds; M A Israel
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

10.  The protein encoded by the human proto-oncogene c-myc.

Authors:  G Ramsay; G I Evan; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more
  7 in total

1.  Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.

Authors:  J Bigler; W Hokanson; R N Eisenman
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

2.  Degradation of nuclear oncoproteins by the ubiquitin system in vitro.

Authors:  A Ciechanover; J A DiGiuseppe; B Bercovich; A Orian; J D Richter; A L Schwartz; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 3.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

4.  Organization and expression of the chicken N-myc gene.

Authors:  S Sawai; K Kato; Y Wakamatsu; H Kondoh
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

5.  Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells.

Authors:  P J Koskinen; L Sistonen; G Evan; R Morimoto; K Alitalo
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  A fusion protein formed by L-myc and a novel gene in SCLC.

Authors:  T P Mäkelä; K Saksela; G Evan; K Alitalo
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

7.  The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells.

Authors:  A Wenzel; C Cziepluch; U Hamann; J Schürmann; M Schwab
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.